Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -6.40 -12.7% 44.00 47.90 48.00 52.00 47.90 50.60 760,179 16:46:08
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -2.9 -1.0 - 113

Futura Medical Share Discussion Threads

Showing 20626 to 20642 of 21575 messages
Chat Pages: Latest  827  826  825  824  823  822  821  820  819  818  817  816  Older
DateSubjectAuthorDiscuss
25/3/2021
07:54
people will use it regardless of erection issues because you rub it to erection as many times you like to satisfy very hot birds. Fantastic isn’t it. Since it is a gel not drug , it won’t have any side effects apart from giving pleasure , lubrication and enjoyable time to hot birds
sightwatcher
25/3/2021
07:47
As I said previously some people may quite rightly have questioned the annual remuneration of the Directors in Futura in light of all the product failures. https://uk.advfn.com/cmn/fbb/thread.php3?id=33313581&from=3478 But what many have really questioned over the years is why they hold and buy such small amounts of shares themselves. The answer is out there and has been since its IPO https://www.standard.co.uk/hp/front/smaller-companies-spotlight-6969560.html Former insurance broker James Barder became involved with Futura having made an investment in what was a private company; pre-Viagra, he, some family and friends all thought it a 'bit of a laugh' initially, but are now very serious. Together they speak for around 25% of the company and many of them came in at the equivalent of 1p a share.
lbo
25/3/2021
07:39
But a placebo may work in a trial when people don’t know its a placebo and just think its an active drug. What happens in the real world when people are told or realise they are just being given a placebo with no active drug component? Will people still want to use and buy a placebo then? One simple comparison study with KY Warming or Durex play Warming/Tingle is all that is now needed to see if MED3000 has any real Product differentiation from what’s already on the market. I did also see another company in America working on a Topical Sildenafil. I also saw they are a working on a female version. Some may remember when Futura had the FLD500 which was dropped https://strategicscience.com/Topical-Sildenafil-ED.html
lbo
25/3/2021
07:03
You say you are not a short term day trader but then make comments that a fleeting intraday share price is how to define creating real medium to long term shareholder value on the back of hyped news. Futura has been here before and had a European CE mark approval awarded for its similar product CSD500. And licensed and launched that product in the EU well the Netherlands and many other territories. Yet here Futura are still years later not generating any Royalties or Revenues. That harsh reality does for a lot of shareholders deserve silence. What else had to be said about it. At least until more no new news is released about the failed MED2005 placebo now called MED3000 getting a CE mark. As if CE marks are guaranteed to generate considerable sales. Not something they look at in the low bar criteria needed for certain non invasive devices in Europe. Durex play and Ky warming also have CE marks. But something real shareholders definitely would need to consider is if this so called new news and share price rise is any different this time and will lead to real value creation and sustained share price appreciation. It was also noteworthy after all the so called news neither Trinity nor Liberum updated their target prices to multiples of 40p. I also gave links to that too. https://assets.publishing.service.gov.uk/media/55cb331ae5274a5473000025/Reckitt_Benckiser_-_K-Y_brand_final_report_Appendices_and_Glossary.pdf The medical device is classified in one of four classes, based on rules using criteria that include invasiveness, duration of continuous contact, nature of tissue contact and whether the device is active or non-active. Most personal lubricants belong to class IIa
lbo
24/3/2021
23:30
LBO 'Many years', of course, except the previous year of complete silence, on any stock. You can't help adding to the layers of bs, can you. If I'm a day trader, then I'll have sold when the price found resistance and started to retreat and bought again when the price found support, but whether I trade short, medium or long term, that doesn't detract from your obvious input of contradictory bs. Top marks for effort though. Still laughing.
viralspec
24/3/2021
23:16
As I said I have been posting on FUM on advfn for many many years and have seen a lot of short term day trader speculators like you come and go too. https://uk.advfn.com/cmn/fbb/thread.php3?id=32626105 Sometimes especially after so many years and false dawns and failures there was nothing left to be said as there was no real new news. But then again it all supposedly happens and kicks off during and after these periods of news hype when again people like you only read and see what they want to see. Also gave links supporting of all that too. Again I do not work for anyone. I will say it again. I have been a shareholder for many years and why you feel the need to personally focus on me instead of focusing on the fundamental facts at hand that have been clearly presented just reaffirms the type of day trader/speculator/momentum trader that you probably are. I advise everyone DYOR especially on the fundamental facts. Don’t listen to me or Viral or a anyone especially on a BB and definitely don’t buy or sell any share based on what anyone else says. Again DYOR.
lbo
24/3/2021
22:29
How is saying the share price has fallen all the way down from 95p is a positive? Thats a negative. The chartists, day traders or whatever you want to call them said all the rest about where they thought the share price was going on supposed technicals. Nothing to do with fundamentals. The last fundraising had to be at 8p it was so bad. I also posted all the links to the pie in the sky potential for this product and clearly showed they were wrong when they did the same on CSD500 a few years ago. I also posted the interview from Labiotech.eu with Angela Hildreth about how bad things got. None of which was positive. Again you only seem to see what you want and only reposting some of my posts. You are displaying clear signa of something called selective reinforcement bias.
lbo
24/3/2021
22:19
They're YOUR posts, LBO, not mine. Hilarious. Here's another, paying particular attention to your last line, that 'you just thought you'd mention' at the time, which was only a few days ago. ______ LBO - 20 Mar 2021 - 09:51:27 - 8682 of 9096 Delta also don't forget that even after the 60p plus the chartists and brokers are now calling is reached. hTTps://www.pscp.tv/w/cyRleXR3LTI4NzQ4ODkyNzV8MWxQSnFYcHlleVlHYo_aYEoWBCOG3ic78f2PaAgc9miICuizy5l4atZ9qRxF?t=1m30s - hxxps://www.research-tree.com/companies/uk/medical-equipment-services/futura-medical-plc/research/liberum/liberum-futura-medical-reaching-the-promised-land-with-european-approval/1_64cb9ef9-9cb6-4850-a8a5-cf91ab6d1e25 hTTps://www.trinitydelta.org/companies/futura-medical/ The share price will still be far below its 2016 high of 95p ________
viralspec
24/3/2021
22:06
Again you only seem to see positives in everything being said. I see the unanswered questions how they “somehow stumble upon a placebo effect that Dermasys alone without the need for adding any active drug like GTN was efficacious in ED” I also see the question about what the FDA will want to see in the confirmatory trial. Which we now know they insisted on 6 months to make sure the placebo effect does not tail off over time. I also see the rest of the statements were actually from Ken James not me and my reading on them was they were to do with the fact that the door was closing on MED2005 after many many years of wasted time and money so the company then needed to salvage something and create an opportunity and open a new door. If they didn’t then Futura was effectively finished as who was going to give them any more money as all the products have basically failed to generate any Revenues after 17 years since IPO.
lbo
24/3/2021
21:51
Here's another of your 'positive agenda' posts before you changed to suit your employers trading position. ______ LBO - 20 Mar 2021 - 09:04:20 - 8680 of 9096 Delta not sure anyone did anything in the end but somehow stumble upon a placebo effect that Dermasys alone without the need for adding any active drug like GTN was efficacious in ED. As Ken correctly said in a webcast after the clinical trial results. Sometimes science gives you unexpected results but creates new opportunities. hTTps://mancunion.com/2021/03/02/scientific-discovery-viagra-and-other-happy-accidents/ I did also see Ken saying back in February there was a meeting with the FDA scheduled too and an update on USA approval would be also coming before end of March. Will be interesting to see what the FDA will want to see in the confirmatory trial. hTTps://www.youtube.com/watch?v=wWjBYz6-ASA
viralspec
24/3/2021
21:39
LBO, FDA didn't ask for blind, why should FUM volunteer. They are promoting a placebo at best. But it's about the money, not the product!
glavey
24/3/2021
17:34
The term was called COINED: Condom INduced Erectile Dysfunction or condom-associated erection problems (CAEPs) Depending on the study, 18 to 36 percent of condom users—roughly one-quarter—report condom-associated erection loss, usually difficulties maintaining firmness once condoms have been rolled over erections. https://www.investorschronicle.co.uk/2011/12/06/tips-and-ideas/share-tips/tips-of-the-week/futura-medical-fum-gzYWSNgGma4WXndOKPDM9O/article.html It was estimated that CSD500 could capture about 6 per cent of the condom branded market, which would mean roughly £35m a year in sales for SSL. Assuming a percentage royalty take for Futura in the late teens, CSD500 could be generating over £6m a year in sales for the group And Futura estimated it would receive royalties of £1.7-2.5m per annum per 1% of global market share. https://www.edisoninvestmentresearch.com/?ACT=18&ID=2666 After all the years of failures I think many shareholders have got FINED: Futura INduced Erectile Dysfunction
lbo
24/3/2021
17:21
never could work out how gel in a condom would work your pencil has already done the job to get the thing on
creditcrunchies
24/3/2021
16:51
Better post this as a follow up to show what is going on out there: https://www.theguardian.com/business/2021/mar/23/new-breed-of-young-investors-taking-big-risks-warns-fca-bitcoin-foreign-exchange There is some very scary stuff in there: "In the FCA-commissioned report, researchers from the consultancy BritainThinks uncovered a “striking” lack of awareness or genuine belief in the hazards associated with investing, with 45% of those questioned not viewing “losing some money” as a potential risk."
sphere25
24/3/2021
16:31
There are always two sides to every story and a lot of news was put out all of a sudden by the company and Trinity after a very quiet period so yes a lot of information had to be digested. Some information was new which got spin in the press and some was old news but just made to look new. And as John Maynard Keynes said "When the facts change, I change my mind" so can anyone. But sadly I don't think the facts have changed substantially for Futura.
lbo
24/3/2021
16:15
I also gave you the links to all the old broker research and company links which also highlighted the size of the condom market that CSD500 was supposed to capture a percentage of. But sadly it never did. Was all that potential back then that ultimately resulted in no royalties in the end “fraud”?
lbo
24/3/2021
16:07
They are all words from the Futura website and all the other links provided in all my posts. Its all there for anyone to read and DYOR. Nobody has been forced to read any of it and can still form their own views. Be they positive or negative.
lbo
Chat Pages: Latest  827  826  825  824  823  822  821  820  819  818  817  816  Older
ADVFN Advertorial
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210517 04:36:09